Stockreport

Athira Pharma Announces Reverse Stock Split

Athira Pharma, Inc.  (ATHA) 
PDF BOTHELL, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (“Athira” or “Company”) (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on de [Read more]